arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

VERACYTE, INC.

VCYT
$23.92 ▼ -28.60 (-54.46%) at close
Healthcare ·Services-Medical Laboratories ·USServices-Medical Laboratories
58 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
67
Health
Good
Neutral
auto_awesome

Analytical Summary

VERACYTE, INC. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $1.9B
Dividend Yield —
Revenue Growth 15.5% ↘
Op. Margin 15.3% ↘
ROIC 1.6% →
FCF / Share $0.54 ↗
Trailing P/E 74.8x
Price / Book 1.4x
FCF Yield 2.3%
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

58-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$150.32M
↑ +15.5% —
Net Income Profit after all expenses
$25.49M
↓ -11.2% —
Operating Margin Operating profit as % of sales
15.3%
↓ -6.1% 59th
FCF / Share Free cash flow per share
$0.54
↑ +32.5% —
Long-Term Debt Long-term obligations
$1.07M
↑ +17.2% —

Health Breakdown

Profitability
72
Returns
54
Cash Quality ↑
85

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 16 years · 58 quarters